- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 291/00 - Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms
Patent holdings for IPC class C07D 291/00
Total number of patents in this class: 23
10-year publication summary
1
|
0
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Aurigene Discovery Technologies Limited | 99 |
3 |
Life Technologies Corporation | 3306 |
2 |
Bristol-myers Squibb Company | 4880 |
1 |
Merck Sharp & Dohme Corp. | 2191 |
1 |
Bayer Cropscience AG | 2040 |
1 |
Sumitomo Chemical Company, Limited | 9043 |
1 |
The United States of America as represented by the Secretary of the Navy | 2753 |
1 |
Board of Regents, The University of Texas System | 5808 |
1 |
Biogen MA Inc. | 894 |
1 |
Cynora GmbH | 202 |
1 |
Joyant Pharmaceuticals, Inc. | 10 |
1 |
Mitokinin LLC | 3 |
1 |
Receptos LLC | 63 |
1 |
Rutgers, The State University of New Jersey | 1893 |
1 |
Salix Pharmaceuticals, Ltd. | 46 |
1 |
Whitehead Institute for Biomedical Research | 320 |
1 |
Mitokinin. Inc. | 22 |
1 |
Cothera BioScience, Inc. | 18 |
1 |
Merck Sharp & Dohme LLC | 3751 |
1 |
Nantong Hongxin Chemical Co., Ltd. | 1 |
1 |
Other owners | 0 |